Castle Biosciences CSTL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Castle Biosciences’s reported figures.
Based on trailing twelve months.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's asset turnover?
- Castle Biosciences (CSTL) reported asset turnover of 0.6× in Q1 2026.
- How has Castle Biosciences's asset turnover changed year-over-year?
- Castle Biosciences's asset turnover decreased by 10.4% year-over-year, from 0.7× to 0.6×.
- What is the long-term trend for Castle Biosciences's asset turnover?
- Over 5 years (2020 to 2025), Castle Biosciences's asset turnover has grown at a 22.6% compound annual growth rate (CAGR), from 0.2× to 0.6×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.